inno.N's Production Site
With a global Standard IT system and priority placed on the data integrity, inno.N operates a quality management system in accordance with the standards of cGMP/EU GMP.
Enterprise Quality Management System
-
Quality
ManagementPolicies to improve product quality are established and a quality management system is operated. -
Quality
AssuranceThe quality of drugs is guaranteed by meeting cGMP standards. -
Quality
ImprovementThrough technological support, inno.N aims not only to offer good products, but those that meet some of the most stringent quality standards. -
Quality
AuditsThrough continuous quality audits, one of the most thorough quality management systems is maintained and managed.
About the quality system
![](/assets/front/pc/img/company/system_img01_en.png)
Quality Policy
OUR MISSION
Heal the World for a Better Life
Code of Conduct
- We always listen to our customers and do our best to respond to their needs, fulfilling our social responsibilities for the patients suffering from disease and their families.
- We constantly improve with the New Frontier spirit for better quality.
- We follow principles and standards for quality and act honestly.
- We strive to have the appropriate members and systems to improve quality.
![](/assets/front/pc/img/company/standard_img.png)
One of the most cutting-edge production facilities for pharmaceutical products in Korea that meets global standards, the Osong Plant is where high quality oral solid dosage products, Oncology Injectables and IV fluids are manufactured.
![](/assets/front/pc/img/company/infra_01_view.png)
-
01
Compliance with cGMP/EU GMP
-
02
Cutting-edge manufacturing facilities and an IT system for the full production process
-
03
Production technologies and hands-on experience from over 30 years in the industry
-
04
Compliance with global standards for safety and environment
Address | 239, Osong Saengmyeong 2 Ro, Osong-Eup, Heungdeok-Gu, Cheongju-Si, Chungcheongbuk-Do, Korea |
---|---|
Area of the site | 146,013 m² |
Area of the buildings | 58,896 m² |
Key facilities | 12 buildings specializing each in the manufacturing of oral solid dosage products, Oncology Injectables and IV fluids |
Dosage forms of products | Oral solid dosage products, Oncology Injectables and IV fluids |
Certifications | KOSHA-MS, ISO 45001, ISO 14001, KGMP |
Oral solid dosage products
![](/assets/front/pc/img/company/infra_01_img01.png)
![](/assets/front/pc/img/company/infra_01_img02.png)
Oncology Injectables
![](/assets/front/pc/img/company/infra_01_img03.png)
![](/assets/front/pc/img/company/infra_01_img04.png)
One of the largest smart factory in Korea with the latest automated facilities, the Osong IV Plant manufactures some of the highest quality IV products.
![](/assets/front/pc/img/company/infra_02_view.png)
-
01
One of the largest production capacities in Korea with the latest automated facilities
-
02
A smart factory that operates based on Big Data analysis and forecasting
-
03
An environment-friendly production facility using renewable energy sources such as solar power
-
04
A global quality management system is implemented to ensure the highest quality in products
Address | 239, Osong Saengmyeong 2 Ro, Osong-Eup, Heungdeok-Gu, Cheongju-Si, Chungcheongbuk-Do, Korea |
---|---|
Area of the site | 146,013 m² |
Area of the buildings | 32,191 m² |
Key facilities | Production lines in the IV building, automated warehouses and utilities |
Dosage forms of products | Oral solid dosage products, Oncology Injectables and IV fluids |
Certifications | KOSHA-MS, ISO 45001, ISO 14001, KGMP |
IV fluids
![](/assets/front/pc/img/company/infra_02_img01.png)
![](/assets/front/pc/img/company/infra_02_img02.png)
![](/assets/front/pc/img/company/infra_02_img03.png)
![](/assets/front/pc/img/company/infra_02_img04.png)
![](/assets/front/pc/img/company/infra_02_img05.png)
![](/assets/front/pc/img/company/infra_02_img06.png)
IV fluids, cephalosporin antibiotics (finished products, APIs), general APIs are manufactured and supplied to domestic and international customers.
![](/assets/front/pc/img/company/infra_03_view.png)
-
01
A CMO of over 20 years with a major Japanese pharmaceutical firm
-
02
Specialized technologies for IV fluid production and automated facilities that meet GMP standards
-
03
Production facilities entirely dedicated to the API of K-CAB tablets, Tegoprazan
-
04
Over 20 years’ experience in manufacturing antibiotics of aseptic processing
Address | 20 Daeso Sandan-Ro, Daeso-Myeon, Eumseong-Gun, Chungcheongbuk-Do, Korea |
---|---|
Area of the site | 58,278m² |
Area of the buildings | 28,411m² |
Key facilities | Twenty-five buildings including those dedicated for IV fluids, Tegoprazan, cephalosporin antibiotics, and TPN. |
Dosage forms of products | IV fluids, oral solid dosage products, API for cephalosporin, General API |
Certifications | KOSHA-MS, ISO45001, KGMP, PMDA, Iran FDA |
Tegoprazan
![](/assets/front/pc/img/company/infra_03_img01.png)
![](/assets/front/pc/img/company/infra_03_img02.png)
IV fluids
![](/assets/front/pc/img/company/infra_03_img03.png)
![](/assets/front/pc/img/company/infra_03_img04.png)
Antibiotics
(Cephalosporin)
![](/assets/front/pc/img/company/infra_03_img05.png)
![](/assets/front/pc/img/company/infra_03_img06.png)
Antibiotics
(Cephalosporin API)
![](/assets/front/pc/img/company/infra_03_img07.png)
![](/assets/front/pc/img/company/infra_03_img08.png)
With over 30 years of experience in manufacturing biopharmaceutical products, the Plant supplies its products to domestic and international customers.
![](/assets/front/pc/img/company/infra_04_view.png)
-
01
Vaccine production facilities that are GMP-compliant
-
02
With over 20 products registered in a number of countries including Thailand
-
03
A quality management system to ensure the manufacturing of premium quality products
-
04
Production technologies and hands-on experience from over 30 years in the industry
Address | 811 Deokpyeong-Ro, Majang-Myeon, Icheon-Si, Gyeonggi-Do, Korea |
---|---|
Area of the site | 34,751 m² |
Area of the buildings | 14,492 m² |
Key facilities | 10 buildings including those specialized for the production of vaccines and Epokine, and for quality management |
Dosage forms of products | Biological products (e.g. vaccines and genetic recombination drugs), antibiotic injections |
Certifications | KOSHA-MS, KGMP, TFDA, NADFC, Philippines FDA |
Injections
![](/assets/front/pc/img/company/infra_04_img01.png)
![](/assets/front/pc/img/company/infra_04_img02.png)
Epokine
![](/assets/front/pc/img/company/infra_04_img03.png)
![](/assets/front/pc/img/company/infra_04_img04.png)
Vaccines
![](/assets/front/pc/img/company/infra_04_img05.png)
![](/assets/front/pc/img/company/infra_04_img06.png)
With the establishment of a highly reliable GMP Cell Center, HK inno.N has been leading the industry in the development and manufacturing of Advanced Therapy Medicinal Products.
![](/assets/front/pc/img/company/infra_05_view.png)
-
01
One of Korea’s largest automated production facilities with a closed system
-
02
Cell & Gene Therapy production facilities that are GMP-compliant
-
03
A top-notch quality management system to ensure high quality products are manufactured
-
04
Infrastructure for the development and optimization of CGT processes
Address | Building D, 947 Hanamdaero, Hanam-Si, Gyeonggi-Do, Korea |
---|---|
Area of the site | Approximately 1,508 m2 or 457 pyeong |
Key facilities | Process development lab, Quality testing and analysis lab, Aseptic manufacturing room, Storage room |
Product formats manufactured | Advanced Therapy Medicinal Products (for Cell & Gene Therapy) |
Permission | Permission for Manufacturing Advanced Biological Products (2022.08) Permission for Management Business of Human Cells (2023.09) |
Process development lab
![](/assets/front/pc/img/company/infra_05_img01.png)
![](/assets/front/pc/img/company/infra_05_img02.png)
Quality testing and analysis lab
![](/assets/front/pc/img/company/infra_05_img03.png)
![](/assets/front/pc/img/company/infra_05_img04.png)
Aseptic manufacturing room
![](/assets/front/pc/img/company/infra_05_img05.png)
![](/assets/front/pc/img/company/infra_05_img06.png)